Oral GLP-1 medications may be a reasonable option for: Patients early in their weight loss journey Patients with mild to moderate weight loss goals Patients who strongly prefer to avoid injections They may be less ideal for: Patients who have had bariatric surgery Patients needing significant weight loss Patients who have not responded to oral medications in the past The decision is not just about preference
On a broader societal level, the use of GLP-1 medications for weight loss may be reinforcing the negative stigmas around fatness and being overweight that often contribute to the development of eating disorders
When your trial is over, youll be automatically charged a monthly subscription fee
Upon dispensing, the patient may store non-reconstituted tesamorelin at refrigerated temperature until the expiration date, or at or below 25C (77F) for 3 months or until the expiration date, whichever occurs first
Its popular among those looking to optimize performance, recovery, and body composition
2026 Regulatory Update: On April 15, 2026 the FDA removed both BPC-157 and TB-500 from its Category 2 restricted list